Recent Updates November 24, 2025: Updated Sheds treatment options to remove Ozempic and Mounjaro and add Zepbound
Who Should Avoid GLP-1 Medications GLP-1 treatments are generally not recommended for: Individuals with certain thyroid conditions Those with a history of specific endocrine disorders People who are pregnant or planning a pregnancy Anyone advised against it by a healthcare provider This is why eligibility screening is essential before starting treatment
Our policy allows the sale of dietary supplements if they comply with applicable regulations as well as federal, state and local laws, and FTC guidelines, Cromwell said, adding that the company would be likely to review products marketed as GLP-1 supplements and remove them if found to make inappropriate or inaccurate claims. [The wellness market] has continued to prey on the desperate, and these are people who have poor access, Butsch said
However, it remains under investigation whether these benefits are directly due to the GLP-1 agonists or a result of the weight loss they facilitate
The opportunity space extends to developing specialized food products, supplements, and meal delivery services calibrated to the unique needs of this growing consumer segment
